Search
for
Sort by
Research 241–270 of 742
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
- Oligomenorrhoea in Exercising Women
- Hyperandrogenism in Adolescent Girls
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- Finasteride in the Treatment of Hirsutism
- Hirsutism
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Polymorphism of CAG and GGN repeats of androgen receptor gene in women with polycystic ovary syndrome
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Polycystic ovary syndrome: a dermatologic approach
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Clinical manifestations of polycystic ovary syndrome
- HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome
- Can serum vaspin levels predict clomiphene resistance in infertile women with PCOS?
- Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome
- Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment
- Evaluation of serum level of omentin‐1 in females with hirsutism
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- PCOS and Obesity: Contraception Challenges
- Serum 1, 25-dihydroxy vitamin D- vitamin D3- among obese Egyptian women with polycystic ovary syndrome
- Study of Cutaneous Manifestations of Polycystic Ovarian Syndrome
- Clinical use of 5α-reductase inhibitors
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Polyzystisches Ovar-Syndrom (PCOS)
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care